Advertisement
Advertisement

KYNB

K

Kyntra Bio, Inc. Common Stock

6.95
USD
Sponsored
-0.15
-2.11%
May 08, 15:52 UTC -4
Closed
exchange

After-Market

6.93

-0.02
-0.29%

Kyntra Bio, Inc. Common Stock Profile

About

Kyntra Bio is a biopharmaceutical company focused on development of novel therapies in oncology and rare disease. Kyntra Bio, formerly known as FibroGen Inc., is based in SAN FRANCISCO.

Info & Links

CEO

Thane Wettig

Headquarters

350 Bay Street, Suite 100, #6009
SAN FRANCISCO, CA 94133, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.kyntrabio.com

Auditor

PricewaterhouseCoopers LLP

Share holders

80

Employees

34

Kyntra Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

28.05M

Enterprise Value

-19.82M

Enterprise Value/EBITDA(ttm)

0.44

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

4.52

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

92.05%

Operating Margin(ttm)

-800.81%

Profit Margin(ttm)

4284.57%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

435.36%

Return on Assets(ttm)

-34.39%

Income Statement

Revenue(ttm)

6.44M

Revenue Per Share(ttm)

1.59

Gross Profit(ttm)

5.88M

EBITDA(ttm)3

-45.22M

Net Income Available to Common(ttm)

183.45M

Diluted EPS(ttm)

45.47

Share Statistics

Beta (5Y Monthly)

0.90

52-Week Change

--

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

4.05M

Dividend Yield

0.00%

Float4

3.97M

% Held by Insiders

1.98%

% Held by Institutions

72.71%

Balance Sheet

Total Cash(mrq)

88.98M

Total Cash Per Share(mrq)

21.99

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.39%

Quick Ratio(mrq)

3.26%

Book Value Per Share(mrq)

-4.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.18

Free Cash Flow(ytd)

-4.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement